Your Location:
Home >
Browse articles >
Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance
OriginalPaper | Updated:2021-08-27
    • Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance

    • Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance

    • 中国结合医学杂志(英文版)   2018年24卷第2期 页码:125-132
    • DOI:10.1007/s11655-016-2252-4    

      中图分类号:
    • 纸质出版日期:2018

      网络出版日期:2016-5-10

    Scan for full text

  • Jiang, Wn., Li, D., Jiang, T. et al. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance., Chin. J. Integr. Med. 24, 125–132 (2018). https://doi.org/10.1007/s11655-016-2252-4 DOI:

    Wei-ning Jiang, Dan Li, Tao Jiang, et al. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance[J]. Chinese Journal of Integrative Medicine, 2018,24(2):125-132. DOI: 10.1007/s11655-016-2252-4.

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

4

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Effects of Portulaca oleracea on insulin resistance in rats with type 2 diabetes mellitus
Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease
Potent therapeutic effects of Shouwu Jiangqi Decoction (首乌僵芪汤) on polycystic ovary syndrome with insulin resistance in rats
Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

相关作者

暂无数据

相关机构

Institute of Integrated Traditional & Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Guangdong Research Center of Metabolic Diseases of Integrated Western and Chinese Medicine, Guangdong Pharmaceutical University
Joint Laboratory between Guangdong and Hong Kong on Metabolic Disease, Guangdong Pharmaceutical University
State Key Laboratory of Pharmaceutical Biotechnology, the University of Hong Kong
Zhangjiagang Hospital of Chinese Medicine, Zhangjiagang
0